pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·May 4·1 min read
save

FDA search for new CBER head focused on small group of final candidates

The FDA has narrowed its search for a new leader of its Center for Biologics Evaluation and Research to three or four final candidates, according to a person familiar with the matter. The agency hopes ...

May 4, 2026·read at Endpoints ↗

FDA Commissioner Marty Makary speaks at the annual Milken Institute Global Conference in Los Angeles on May 4, 2026 (Drew Armstrong for Endpoints News) May 4, 2026 12:36 PM EDT FDA+ Ex­clu­sive: FDA search for new CBER head fo­cused on small group of fi­nal can­di­dates Drew Armstrong Executive Editor Max Bayer Senior Reporter The FDA has nar­rowed its search for a new leader of its Cen­ter for Bi­o­log­ics Eval­u­a­tion and Re­search to three to four fi­nal can­di­dates, ac­cord­ing … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
113 words · retrieved May 4
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 1h agoNovartis' drug delivery deal with Alteogen; More worker cuts at CellaresEndpoints
  • 1h agoPfizer shares ADC rights with Medicus; RevMed updates lung cancer dataEndpoints
  • 2h agoAbbVie claims Phase 3 win for multiple myeloma drug etentamigEndpoints
  • 3h agoHealth tech investors are looking at bigger betsEndpoints
  • 5h agoSummit, Akeso say ivonescimab clears OS bar in Phase 3 lung cancer trialEndpoints